ASTRAZENECA: UBS favorable on the file








In a research note published by Michael Leuchten, the broker UBS advises to be interested in the title with a buying opinion. The price target remains unchanged at 10,000 GBX.

Zonebourse with dpa-AFX Analyzer 2022

All the news about ASTRAZENECA PLC

Analyst Recommendations for ASTRAZENECA PLC

2021 turnover 36,239m
–
31,883M
2021 net result 2,055M
–
1,808M
Net debt 2021 24,994M
–
21,989M
PER 202161.1x
2021 performance2.31%
Capitalization 188 billion
188 billion
166 billion
VE / CA 20215.88x
VE / CA 20224.84x
Number of employees76 100
Floating96.4%

Chart ASTRAZENECA PLC


Tough :

Period:




AstraZeneca PLC : Chart technical analysis AstraZeneca PLC | Market area

Trends technical analysis ASTRAZENECA PLC

Short termMiddle termLong term
TrendsbullishNeutralbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts24
Last Closing Price

$121.49

Average price target

$138.47

Deviation / Average Target 14.0%

Officers and Directors




Source link -88